LeMaitre Vascular (LMAT) director converts dividend rights to common stock
Rhea-AI Filing Summary
LeMaitre Vascular director John A. Roush exercised dividend equivalent rights on 12/12/2025, converting a total of 10 rights into an equal number of common shares at $0.0000 per share. After these conversions he holds 3,465 LMAT shares directly and 181.0000 shares indirectly through his spouse. Footnotes explain that these rights were released upon vesting of restricted and performance stock unit awards granted on 12/12/2022, with any fractional rights settled in cash.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10 shares
Net Buy
5 txns
Insider
Roush John A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Dividend Equivalent Rights | 5 | $0.00 | $0.00 |
| Exercise | Dividend Equivalent Rights | 5 | $0.00 | $0.00 |
| Exercise | Common Stock | 5 | $0.00 | $0.00 |
| Exercise | Common Stock | 5 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Dividend Equivalent Rights — 0 shares (Direct);
Common Stock — 3,465 shares (Direct);
Common Stock — 181 shares (Indirect, Indirect through spouse)
Footnotes (4)
- F1. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- F2. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- F3. Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero.
- F4. These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Key Figures
Dividend equivalent rights converted: 10 rights
Direct common stock holding: 3,465 shares
Indirect common stock holding: 181.0000 shares
+2 more
5 metrics
Dividend equivalent rights converted
10 rights
Total rights exercised and converted into common stock on 12/12/2025
Direct common stock holding
3,465 shares
Post-transaction direct ownership by John A. Roush
Indirect common stock holding
181.0000 shares
Shares held indirectly through spouse after the transaction
Exercise price per share
$0.0000 per share
Price reported for common stock acquired from dividend equivalent rights
Award grant date
12/12/2022
Grant date of restricted and performance stock unit awards linked to the rights
Key Terms
Dividend Equivalent Rights, restricted stock unit award, performance stock unit award, economic equivalent
4 terms
Dividend Equivalent Rights financial
"Represents shares acquired upon release of dividend equivalent rights, on a one-for-one basis."
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock unit award financial
"released in connection with the vesting of a restricted stock unit award granted on 12/12/2022."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
performance stock unit award financial
"released in connection with the vesting of a performance stock unit award granted on 12/12/2022."
economic equivalent financial
"Each dividend equivalent right is the economic equivalent of one share of common stock."
FAQ
What did LeMaitre Vascular (LMAT) director John A. Roush report in this Form 4?
John A. Roush reported exercising dividend equivalent rights and converting 10 rights into common stock on 12/12/2025. Following these transactions, he holds 3,465 LMAT shares directly and 181.0000 shares indirectly through his spouse.
How many dividend equivalent rights did LMAT’s John A. Roush convert into common stock?
Roush converted a total of 10 dividend equivalent rights into common stock on 12/12/2025. Each right is the economic equivalent of one share of LeMaitre Vascular’s common stock, as described in the filing footnotes.
What are dividend equivalent rights in the context of LMAT’s Form 4 filing?
Dividend equivalent rights are instruments that are the economic equivalent of one share of common stock. In this LMAT filing, they were released upon vesting of restricted and performance stock unit awards granted on 12/12/2022.
What is John A. Roush’s direct common stock holding in LMAT after the reported transactions?
After the reported conversions, Roush’s direct holding is 3,465 shares of LeMaitre Vascular common stock. This figure is the authoritative post-transaction balance reported as his direct ownership position in the filing data.
Which awards were tied to the dividend equivalent rights exercised by LMAT’s John A. Roush?
The dividend equivalent rights were tied to restricted stock unit and performance stock unit awards granted on 12/12/2022. Footnotes state that these rights were released upon vesting, with any fractional shares settled in cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
